Małgorzata Iwoła

The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms

Martyna Borowczyk, Marzena Wojtaszewska, Krzysztof Lewandowski et al. · Thrombosis Research · 2014 · 84 citations

Medicine, Genetics, Hematology +16

Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene

Marta Barańska, Krzysztof Lewandowski, Michał Gniot et al. · Journal of Applied Genetics · 2008 · 25 citations

Medicine, Genetics, Molecular Genetics +9

Frequency and Molecular Characteristics of Calreticulin Gene <b><i>(CALR)</i></b> Mutations in Patients with <b><i>JAK2</i></b>-Negative Myeloproliferative Neoplasms

Marzena Wojtaszewska, Małgorzata Iwoła, Krzysztof Lewandowski · Acta Haematologica · 2014 · 19 citations

Life Sciences, Genetics, Molecular Genetics +12

Coexistence of <i>JAK2</i> or <i>CALR</i> mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Krzysztof Lewandowski, Michał Gniot, Marzena Wojtaszewska et al. · International Journal of Laboratory Hematology · 2018 · 13 citations

Medicine, Genetics, Hematology +17